Free Trial

TrueBlue (TBI) Stock Price, News & Analysis

$7.40
-0.35 (-4.52%)
(As of 09/6/2024 ET)
Today's Range
$7.28
$7.77
50-Day Range
$7.40
$12.12
52-Week Range
$7.28
$16.14
Volume
216,804 shs
Average Volume
348,265 shs
Market Capitalization
$226.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.50

TrueBlue MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
68.9% Upside
$12.50 Price Target
Short Interest
Healthy
4.06% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.34) to $1.16 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.78 out of 5 stars

Business Services Sector

160th out of 303 stocks

Help Supply Services Industry

11th out of 15 stocks

TBI stock logo

About TrueBlue Stock (NYSE:TBI)

TrueBlue, Inc., together with its subsidiaries, provides specialized workforce solutions in the United States, Canada, the United Kingdom, Australia, and Puerto Rico. It operates through three segments: PeopleReady, PeopleManagement, and PeopleScout. The company PeopleReady segment provides general, industrial, and skilled trade contingent staffing services for construction, transportation, manufacturing, retail, hospitality, and renewable energy industries. The PeopleManagement segment offers contingent, on-site industrial staffing, and commercial driver services, which includes on-site management and recruitment for the contingent industrial workforce of manufacturing, warehousing, and distribution facilities; and recruitment and management of contingent and dedicated commercial drivers to the transportation and distribution industries under the Staff Management, SIMOS Insourcing Solutions, and Centerline Drivers brands. The company PeopleScout segment provides recruitment process outsourcing, talent advisory services, and managed service provider solutions including sourcing, screening, hiring, and onboarding services; operates Affinix, a technology platform for sourcing, screening, and delivering a permanent workforce to its clients; talent advisory services, such as employer branding, recruitment marketing, talent insights, diversity, equity and inclusion consulting, candidate assessment, and talent acquisition strategy consulting services; and contingent labor programs including vendor selection, performance management, compliance monitoring, and risk management. TrueBlue, Inc. was formerly known as Labor Ready, Inc. and changed its name to TrueBlue, Inc. in December 2007. The company was incorporated in 1985 and is headquartered in Tacoma, Washington.

TBI Stock Price History

TBI Stock News Headlines

Q2 2024 TrueBlue Inc Earnings Call
The death of Nvidia?
Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.
TrueBlue Reports Second Quarter 2024 Results
The death of Nvidia?
Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.
TrueBlue earnings preview: what to expect
TrueBlue to Announce Second Quarter 2024 Results
TrueBlue to Announce Second Quarter 2024 Results
See More Headlines
Receive TBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TrueBlue and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/05/2024
Today
9/07/2024
Next Earnings (Estimated)
10/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Help supply services
Sub-Industry
Human Resource & Employment Services
CUSIP
89785X10
Employees
5,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$12.50
High Stock Price Target
$13.00
Low Stock Price Target
$12.00
Potential Upside/Downside
+68.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-14,170,000.00
Pretax Margin
-4.64%

Debt

Sales & Book Value

Annual Sales
$1.76 billion
Cash Flow
$1.31 per share
Book Value
$11.05 per share

Miscellaneous

Free Float
29,347,000
Market Cap
$226.22 million
Optionable
Optionable
Beta
1.50
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Ms. Taryn R. OwenMs. Taryn R. Owen (Age 45)
    CEO, President & Director
    Comp: $1.47M
  • Mr. Carl R. Schweihs (Age 39)
    Chief Financial Officer
    Comp: $803.24k
  • Mr. Garrett R. Ferencz (Age 47)
    Executive VP, General Counsel, Chief Ethics & Compliance Officer and Chief Legal Officer
    Comp: $801.89k
  • Mr. Richard P. Betori (Age 63)
    President of PeopleScout
    Comp: $622.69k
  • Ms. Kristy Willis (Age 54)
    President of PeopleReady
    Comp: $622.34k
  • Mr. Richard B. Christensen (Age 47)
    Senior VP, Chief Accounting Officer & Treasurer
  • Mr. Jeff Dirks
    Chief Technology & Information Officer
  • Ms. Caroline Sabetti
    Chief Marketing & Communications Officer
  • Mr. Greg Netolicky
    Chief People Officer
  • Mr. Anthony Brew
    Chief Diversity Officer

TBI Stock Analysis - Frequently Asked Questions

How have TBI shares performed this year?

TrueBlue's stock was trading at $15.34 at the start of the year. Since then, TBI shares have decreased by 51.8% and is now trading at $7.40.
View the best growth stocks for 2024 here
.

How were TrueBlue's earnings last quarter?

TrueBlue, Inc. (NYSE:TBI) announced its earnings results on Monday, August, 5th. The business services provider reported ($0.35) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.05) by $0.30. The firm's revenue was down 16.7% compared to the same quarter last year.

What is Patrick Beharelle's approval rating as TrueBlue's CEO?

34 employees have rated TrueBlue Chief Executive Officer Patrick Beharelle on Glassdoor.com. Patrick Beharelle has an approval rating of 56% among the company's employees. This puts Patrick Beharelle in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are TrueBlue's major shareholders?

Top institutional investors of TrueBlue include Pzena Investment Management LLC (9.39%), Dimensional Fund Advisors LP (5.90%), Azarias Capital Management L.P. (4.08%) and American Century Companies Inc. (1.90%). Insiders that own company stock include Taryn R Owen, Garrett Ferencz, Richard P Betori, Carl Schweihs, Kristy A Fitzsimmons-Willis, Kim Harris Jones, Kristi A Savacool, Robert C Kreidler, William C Goings, Richard Christensen and Derrek Lane Gafford.
View institutional ownership trends
.

How do I buy shares of TrueBlue?

Shares of TBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of TrueBlue own?

Based on aggregate information from My MarketBeat watchlists, some other companies that TrueBlue investors own include International Business Machines (IBM), Intel (INTC), NVIDIA (NVDA), Vertex Pharmaceuticals (VRTX), Gilead Sciences (GILD), The Goldman Sachs Group (GS) and AT&T (T).

This page (NYSE:TBI) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners